Epigenetic suppression of human telomerase (hTERT) is mediated by the metastasis suppressor NME2 in a G-quadruplex-dependent fashion

J Biol Chem. 2017 Sep 15;292(37):15205-15215. doi: 10.1074/jbc.M117.792077. Epub 2017 Jul 17.

Abstract

Transcriptional activation of the human telomerase reverse transcriptase (hTERT) gene, which remains repressed in adult somatic cells, is critical during tumorigenesis. Several transcription factors and the epigenetic state of the hTERT promoter are known to be important for tight control of hTERT in normal tissues, but the molecular mechanisms leading to hTERT reactivation in cancer are not well-understood. Surprisingly, here we found occupancy of the metastasis suppressor non-metastatic 2 (NME2) within the hTERT core promoter in HT1080 fibrosarcoma cells and HCT116 colon cancer cells and NME2-mediated transcriptional repression of hTERT in these cells. We also report that loss of NME2 results in up-regulated hTERT expression. Mechanistically, additional results indicated that the RE1-silencing transcription factor (REST)-lysine-specific histone demethylase 1 (LSD1) co-repressor complex associates with the hTERT promoter in an NME2-dependent way and that this assembly is required for maintaining repressive chromatin at the hTERT promoter. Interestingly, a G-quadruplex motif at the hTERT promoter was essential for occupancy of NME2 and the REST repressor complex on the hTERT promoter. In light of this mechanistic insight, we studied the effects of G-quadruplex-binding ligands on hTERT expression and observed that several of these ligands repressed hTERT expression. Together, our results support a mechanism of hTERT epigenetic control involving a G-quadruplex promoter motif, which potentially can be targeted by tailored small molecules.

Keywords: G-quadruplex; NME2; REST repressor complex; chromatin modification; epigenetics; telomerase reverse transcriptase (TERT); transcription regulation.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Substitution
  • Carcinoma / enzymology
  • Carcinoma / metabolism*
  • Carcinoma / pathology
  • Cell Line, Tumor
  • Cells, Cultured
  • Chromatin Immunoprecipitation
  • Epigenetic Repression*
  • Fibrosarcoma / enzymology
  • Fibrosarcoma / metabolism*
  • Fibrosarcoma / pathology
  • G-Quadruplexes*
  • Genes, Reporter
  • Histone Demethylases / chemistry
  • Histone Demethylases / metabolism
  • Humans
  • Mutagenesis, Site-Directed
  • NM23 Nucleoside Diphosphate Kinases / antagonists & inhibitors
  • NM23 Nucleoside Diphosphate Kinases / chemistry
  • NM23 Nucleoside Diphosphate Kinases / genetics
  • NM23 Nucleoside Diphosphate Kinases / metabolism*
  • Neoplasm Proteins / antagonists & inhibitors
  • Neoplasm Proteins / chemistry
  • Neoplasm Proteins / genetics
  • Neoplasm Proteins / metabolism
  • Point Mutation
  • Promoter Regions, Genetic*
  • Protein Multimerization
  • RNA Interference
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / metabolism
  • Repressor Proteins / antagonists & inhibitors
  • Repressor Proteins / chemistry
  • Repressor Proteins / genetics
  • Repressor Proteins / metabolism
  • Telomerase / antagonists & inhibitors
  • Telomerase / genetics
  • Telomerase / metabolism*

Substances

  • NM23 Nucleoside Diphosphate Kinases
  • Neoplasm Proteins
  • RE1-silencing transcription factor
  • Recombinant Proteins
  • Repressor Proteins
  • Histone Demethylases
  • KDM1A protein, human
  • NME1 protein, human
  • NME2 protein, human
  • TERT protein, human
  • Telomerase